EXPLORE44 Trademark

Trademark Overview


On Monday, September 19, 2022, a trademark application was filed for EXPLORE44 with the United States Patent and Trademark Office. The USPTO has given the EXPLORE44 trademark a serial number of 97597519. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2024. This trademark is owned by Avidity Biosciences, Inc.. The EXPLORE44 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and related diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes.

providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
explore44

General Information


Serial Number97597519
Word MarkEXPLORE44
Filing DateMonday, September 19, 2022
Status700 - REGISTERED
Status DateTuesday, November 5, 2024
Registration Number7560049
Registration DateTuesday, November 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and related diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes.
Pseudo MarkEXPLORE FORTY FOUR; EXPLORE FOUR FOUR
Goods and Servicesproviding medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 5, 2022
Primary Code005
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 5, 2022
Primary Code042
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

Trademark Owner History


Party NameAvidity Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, July 10, 2023NON-FINAL ACTION E-MAILED
Thursday, September 22, 2022NEW APPLICATION ENTERED
Wednesday, October 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 28, 2023ASSIGNED TO EXAMINER
Monday, July 10, 2023NON-FINAL ACTION WRITTEN
Monday, July 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 20, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, February 23, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, February 29, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, April 1, 2024ASSIGNED TO PETITION STAFF
Wednesday, April 3, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 31, 2024USE AMENDMENT FILED
Wednesday, July 31, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 1, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 1, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED